Analogue of thalidomide and preparation method
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- CHANGCHUN INST OF APPLIED CHEMISTRY - CHINESE ACAD OF SCI
- Publication Date
- 2005-11-16
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a series of analogues of thalidomide and their preparation methods. Background technique
[0002] Thalidomide, also known as Thalidomide, is a drug marketed in the late 1950s, used for sedation, hypnosis and antiemetic in early pregnancy. But it was soon discovered that the drug had serious teratogenic effects on the fetus. The drug was withdrawn from the market in the early 1960s. In 1965, Israeli doctor Sheskin (Sheskin, J. Clin Pharmacol. Ther. 1965, 6: 303-306) reported that thalidomide could effectively treat erythematous nodular leprosy (ENL). In 1998, FDA (US Food and Drug Administration) approved thalidomide for the treatment of ENL. In my country, thalidomide is the national essential drug for the treatment of leprosy concomitant diseases. In addition to treating ENL, thalidomide has currently known biological activities including immunosuppression, anti-cancer, and anti-HIV-1 virus. The research on thalid...